When may records be considered for authorized medicinal products regarding IP management?

• A. Only one strict method exists.
• B. Alternative record-keeping approaches may be considered in line with local regulatory requirements.
• C. Records are unnecessary if IP is authorized.
• D. Records must be identical across all regions.

Answer: (B)

Managing IP for an authorized medicinal product involves keeping records that reflect patent status, data protection, and any regulatory exclusivity. While these records are essential, there isn’t a single universal method for doing it. Local regulatory requirements guide what needs to be documented, how it should be stored, and for how long. Because of that, alternative record-keeping approaches may be considered as long as they comply with the specific regulations and remain auditable and traceable. Records are needed even when IP is authorized, and practices can vary by region, so they won’t necessarily be identical everywhere.